20 States with the Highest Fertility Rates in the US

In This Article:

In this article, we will be taking a look at the 20 states with the highest fertility rates in the US. If you do not want to learn about the US fertility services market, head straight to the 5 States with the Highest Fertility Rates in the US.

Expanding Horizons: The Global and US Fertility Services Market

The global fertility market is a rapidly growing industry, with the potential to reach $1.7 trillion in total demand for assisted reproductive technology (ART) services which includes in-vitro fertilization (IVF), surrogacy, and fertility medications. According to the Business Research Company, the global fertility services market which was valued at $54.12 billion in 2023, is expected to grow at a compound annual growth rate (CAGR) of 14.7% to reach $62.07 billion in 2024. Globally, the fertility rate has been declining, with the total fertility rate (TFR) projected to decrease from 2.21 in 2022 to 1.83 in 2050 and 1.59 in 2100.

In the United States, the fertility services market is also experiencing growth, with the market being valued at $22 billion in 2022 and is expected to reach $68.32 billion by 2032, growing at a CAGR of 12% during 2023-2032. According to the Centers for Disease Control and Prevention (CDC), around 12% of women in the United States between 15-44 years have difficulty getting pregnant or carrying a pregnancy to term, which makes up around 6 million women in the US struggling with infertility issues, per CDC. If we talk global, around 1 in 6 people are suffering from infertility which makes up around 17.5% of the adult population worldwide. The major players in the global infertility treatment market include Thermo Fisher Scientific Inc. (NYSE:TMO), Cook Group, and Vitrolife, among others.

Thermo Fisher Scientific Inc. (NYSE:TMO) has partnered with Predictive Laboratories to study the genetic factors underlying infertility in women. The collaboration aims to elucidate the genetic basis of conditions like endometriosis, which affects fertility in up to 40% of infertile women according to the American College of Obstetrics and Gynecology. In 2023, Thermo Fisher Scientific Inc. (NYSE:TMO) introduced two new next-generation sequencing-based assays to accelerate fertility research. The Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit are designed to support preimplantation genetic testing for aneuploidy (PGT-A) used in IVF and intracytoplasmic sperm injection (ICSI) research.

The Dynamics of the Global Contraceptives Market 

The global contraceptives market is experiencing significant growth, driven by factors such as the rising need for family planning, increasing awareness of modern contraception, and concerns over health issues associated with teenage pregnancies. The global contraceptives market size is expected to grow from $33 billion in 2023 to $62 billion by 2033, at a CAGR of 6.5%. The contraceptive devices segment, which includes condoms, subdermal implants, and intrauterine devices (IUDs), also holds a significant market share and is expected to grow at a CAGR of 7.3% from 2022 to 2032, based on an anlysis by GM Insights.